ืืฃ ืืืืชFAGR โข EBR
add
Fagron NV
ืฉืขืจ ืกืืืจื ืงืืื
โ19.32ย โโฌ
ืืืื ืืืื
โ19.10ย โโฌ - โ19.42ย โโฌ
ืืืื ืฉื ืชื
โ15.14ย โโฌ - โ20.35ย โโฌ
ืฉืืื ืฉืืง
1.41Bโ EUR
ื ืคื ืืกืืจ ืืืืฆืข
59.22Kโ
ืืืคืื ืจืืื
17.51
ืชืฉืืืช ืืืืืื ื
1.27%
ืืืจืกื ืขืืงืจืืช
EBR
ืืืฉืืช ืฉืืง ืืืื
ืืกืคืื
ืืฆืืจืช ืืื ืกื
ืืื ืกื
ืจืืื ื ืงื
(EUR) | ืืฆืืณ 2024info | ืฉืื ืื ืืฉื ื ืืฉื ื |
---|---|---|
ืืื ืกื | 221.31Mโ | 13.08% |
ืืืฆืืืช ืชืคืขืืืืืช | 68.27Mโ | 19.22% |
ืจืืื ื ืงื | 20.06Mโ | 6.98% |
ืฉืืื ืจืืื ื ืงื | 9.07 | โ-5.32% |
ืจืืืืื ืืื ืื | โ | โ |
ืจืืื ืืคื ื ืจืืืืช, ืืืกืื, ืคืืช ืืืคืืชืืช | 35.57Mโ | 14.87% |
ืฉืืขืืจ ืืก ืืคืงืืืื | 23.27% | โ |
ืืืื
ืกื ืื ืื ืืกืื
ืืืืช ืืืืืช
(EUR) | ืืฆืืณ 2024info | ืฉืื ืื ืืฉื ื ืืฉื ื |
---|---|---|
ืืืืื ืื ืืืฉืงืขืืช ืืืืื ืงืฆืจ | 115.92Mโ | โ-15.55% |
ืกื ืื ืื ืืกืื | 1.08Bโ | 7.60% |
ืืืืช ืืืืืช | 578.16Mโ | 7.20% |
ืืื ืขืฆืื ืืืื | 505.36Mโ | โ |
ืืื ืขืืื | 72.84Mโ | โ |
ืืืคืื ืืื | 2.81 | โ |
ืชืฉืืื ืขื ืื ืืกืื | 7.65% | โ |
ืชืฉืืื ืขื ืืื | 9.29% | โ |
ืชืืจืื ืืืืื ืื
ืฉืื ืื ืืฉืืื ืืืืื ืื
(EUR) | ืืฆืืณ 2024info | ืฉืื ืื ืืฉื ื ืืฉื ื |
---|---|---|
ืจืืื ื ืงื | 20.06Mโ | 6.98% |
ืืืืื ืื ืืคืขืืืืช ืฉืืืคืช | 33.98Mโ | โ-16.46% |
ืืืืื ืืืฉืงืขืืช | โ-13.07Mโ | โ-43.39% |
ืืืืื ืืืืืื | โ-10.80Mโ | 48.26% |
ืฉืื ืื ืืฉืืื ืืืืื ืื | 9.18Mโ | โ-11.75% |
ืชืืจืื ืืืืื ืื ืคื ืื | 18.52Mโ | 10.24% |
ืืืืข ืืืื
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
ืื ื"ื
ืชืืจืื ืืงืื
1990
ืืชืจ
ืขืืืืื
3,828